e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 10, 2011
Merck & Co., Inc
(Exact name of registrant as specified in its charter)
         
New Jersey   1-6571   22-1918501
 
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)
     
One Merck Drive, PO Box 100, Whitehouse Station, NJ   08889-0100
 
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code (908) 423-1000
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


TABLE OF CONTENTS

Item 7.01. Regulation FD Disclosure
Item 9.01. Financial Statements and Exhibits
SIGNATURES
EXHIBIT INDEX
EX-99.1


Table of Contents

Item 7.01. Regulation FD Disclosure
Incorporated by reference are the R&D and Business Briefing Presentations given by certain senior executive officers of Merck & Co., Inc. (the “Company”) on November 10, 2011, attached as Exhibit 99.1.
This information is not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, and is not incorporated by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Additionally, the submission of this report on Form 8-K is not deemed an admission as to the materiality of any information in this report that is required to be disclosed solely by Regulation FD.
Item 9.01. Financial Statements and Exhibits
     (d) Exhibit
     
Exhibit 99.1
  R&D and Business Briefing Presentations given by certain senior executive officers of the Company on November 10, 2011
 
   
SIGNATURES
          Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  MERCK & CO., Inc.
 
 
Date: November 10, 2011  By:   /s/ Katie E. Fedosz    
    Katie E. Fedosz   
    Senior Assistant Secretary   
 


Table of Contents

EXHIBIT INDEX
     
Exhibit    
Number   Description
99.1
  R&D and Business Briefing Presentations given by certain senior executive officers of the Company on November 10, 2011